Cart
sales@molnova.com
Home - Products - Angiogenesis - VEGFR - Anlotinib Dihydrochloride

Anlotinib Dihydrochloride

CAS No. 1360460-82-7

Anlotinib Dihydrochloride( Anlotinib (AL3818) dihydrochloride | AL3818 dihydrochloride )

Catalog No. M19393 CAS No. 1360460-82-7

Anlotinib also known as AL3818 is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Anlotinib Dihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Anlotinib also known as AL3818 is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities.
  • Description
    Anlotinib also known as AL3818 is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities. Upon administration anlotininib targets multiple RTKs including vascular endothelial growth factor receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent may both inhibit angiogenesis and halt tumor cell growth.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Anlotinib (AL3818) dihydrochloride | AL3818 dihydrochloride
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR2| VEGFR3|c-Kit
  • Research Area
    Cancer
  • Indication
    Non-small cell lung Cancer

Chemical Information

  • CAS Number
    1360460-82-7
  • Formula Weight
    480.36
  • Molecular Formula
    C23H24Cl2FN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:87 mg/mL(181.1 mM)
  • SMILES
    Cc1cc2c([nH]1)ccc(c2F)Oc1c2cc(c(cc2ncc1)OCC1(CC1)N)OC.Cl.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yongkun Sun et al. Safety pharmacokinetics and antitumor properties of anlotinib an oral multi-target tyrosine kinase inhibitor in patients with advanced refractory solid tumors. Journal of Hematology & Oncology20169:105
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Vatalanib free base

    A potent, orally available class III receptor tyrosine kinases inhibitor with IC50 of <1 uM for VEGFR, Flt-1, KDR and PDGFRβ.

  • Lariciresinol

    Lariciresinol is an enterolignan precursor, it possesses fungicidal activities by disrupting the fungal plasma membrane and therapeutic potential as a novel antifungal agent for the treatment of fungal infectious diseases in humans. Dietary lariciresinol can attenuate mammary tumor growth and reduce blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.

  • Sparteine sulfate

    Sparteine sulfate is a class 1a antiarrhythmic agent and a sodium channel blocker. It can chelate the bivalents calcium and magnesium.

Sign In Join Free